Finance

Lists
2M6:ETR
Medtronic PLC
78,28 €
+0,80%
(+0,62) 1D
9-окт., 17:35:57 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 2M6...
Open
78,82 €
High
80,00 €
Low
77,70 €
Mkt. cap
113,18 млд
Avg. vol.
1,36 миң
Volume
0,00
52-wk high
91,50 €
52-wk low
62,86 €
No. of employees
95 миң
Open
78,82 €
High
80,00 €
Low
77,70 €
Mkt. cap
113,18 млд
Avg. vol.
1,36 миң
Volume
0,00
52-wk high
91,50 €
52-wk low
62,86 €
No. of employees
95 миң
News stories
From web sources and news partners
Profile
Medtronic plc is an American-Irish medical device company. The company's legal and executive headquarters are in Ireland, while its operational headquarters are in Minneapolis, Minnesota. Medtronic rebased to Ireland following its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue. The company has developed several world-first technologies since its inception, including wearable and implantable pacemakers, the implantable cardioverter-defibrillator, and remote patient monitoring systems. They also created miniaturized devices like the world's smallest pacemaker and spinal cord stimulator. Wikipedia
About Medtronic PLC
CEOGeoffrey S. Martha
Employees95 миң
Founded1949
Headquarters-
SectorMedical device
Last report
2026-ж., 1-сен.
Fiscal period
Q1 2027
1,45 USD / 1,39 USD
+4,51%beat
Revenue / Est. (USD)
9,76 млд / 9,54 млд
+2,21%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. окт.
2026-ж. янв.
2026-ж. апр.
2026-ж. июл.
Revenue
8,96 млд
9,02 млд
9,81 млд
9,76 млд
Cost of goods sold
3,06 млд
3,17 млд
3,40 млд
3,41 млд
Cost of revenue
3,06 млд
3,17 млд
3,40 млд
3,41 млд
Research and development expenses
754,00 млн
722,00 млн
671,00 млн
771,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,94 млд
2,93 млд
3,04 млд
3,17 млд
Operating expense
4,08 млд
4,04 млд
4,25 млд
4,46 млд
Total operating expenses
7,14 млд
7,21 млд
7,64 млд
7,87 млд
Operating income
1,82 млд
1,80 млд
2,16 млд
1,89 млд
Other non operating income
3,00 млн
13,00 млн
154,00 млн
33,00 млн
EBT including unusual items
1,60 млд
1,40 млд
1,84 млд
1,77 млд
EBT excluding unusual items
1,68 млд
1,66 млд
2,16 млд
1,82 млд
Income tax expense
215,00 млн
254,00 млн
575,00 млн
289,00 млн
Effective tax rate
13,47%
18,10%
31,34%
16,35%
Other operating expenses
-29,00 млн
-79,00 млн
126,00 млн
113,00 млн
Net income
1,37 млд
1,14 млд
1,24 млд
1,47 млд
Net profit margin
15,33%
12,68%
12,68%
15,07%
Earnings per share
1,36
1,36
1,55
1,45
Interest and investment income
89,00 млн
102,00 млн
73,00 млн
102,00 млн
Interest expense
-181,00 млн
-181,00 млн
-176,00 млн
-186,00 млн
Net interest expenses
-92,00 млн
-79,00 млн
-103,00 млн
-84,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
2,52 млд
2,52 млд
2,88 млд
2,62 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору